Across TCGA pan-cancer cohorts, UBTFL3 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated UBTFL3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher UBTFL3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBTFL3 expression acts as an unfavorable survival marker, although some lineages such as GBM and SKCM show a favorable association.

STAD, ESCA, and GBM are the cancer types where UBTFL3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.254	0.636	.004	18	view →
ESCA	DFS	Tertile	All	0.232	0.773	.006	18	view →
GBM	OS	Tertile	All	1.000	0.305	.023	9	view →
SKCM	DFS	Tertile	All	1.000	0.614	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: UBTFL3 tumor-vs-normal RNA expression · all UBTFL3 data types